MedPath

tranexamic acid

These highlights do not include all the information needed to use TRANEXAMIC ACID INJECTION safetly and effectively. See full prescribing information for TRANEXAMIC ACID INJECTION. TRANEXAMIC ACID injection, for intravenous useInitial U.S. Approval: 1986

Approved
Approval ID

8004da00-e3d1-4a77-88ec-ccbde822a803

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tranexamic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-5072
Application NumberANDA212676
Product Classification
M
Marketing Category
C73584
G
Generic Name
Tranexamic Acid
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 11, 2020
FDA Product Classification

INGREDIENTS (2)

TRANEXAMIC ACIDActive
Quantity: 100 mg in 1 mL
Code: 6T84R30KC1
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

tranexamic acid - FDA Drug Approval Details